Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.

Featured Stories

Patchwork of Pre-Embryo Rulings Challenges Courts No Photo Available

As a greater number of couples who can't naturally procreate turn to in vitro fertilization, state judges are grappling with an evolvi... (more story)

Joint Operating Deals Get Another Look in Hospital Tie-Ups No Photo Available

Interest in joint operating agreements — sometimes called virtual mergers — is on the rise as more hospitals try to prepare for heavie... (more story)

A New Mental Health Rx? FDA Braces For AI Chatbots No Photo Available

Patients suffering from depression may someday soon get an unusual kind of prescription that doesn’t involve a pill or an injection: D... (more story)